Effects of PEG conjugation on insulin properties (Q34674765)

3 August 2017

1 reference

title

Effects of PEG conjugation on insulin properties (English)

1 reference

3 August 2017

1 reference

Kenneth D Hinds

1 reference

3 August 2017

Sung Wan Kim

series ordinal

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Advanced Drug Delivery Reviews

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

505-530

1 reference

Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Long-acting growth hormones produced by conjugation with polyethylene glycol.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Synthesis and biological activity of polyethylene glycol-mouse nerve growth factor conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Preparation and properties of polyethylene glycol-trypsin adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Modification of E. coli L-asparaginase with polyethylene glycol: Disappearance of binding ability to anti-asparaginase serum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Modification of human hemoglobin with polyethylene glycol : a new candidate for blood substitute

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Synthesis, isolation, and characterization of conjugates of ovalbumin with monomethoxypolyethylene glycol using cyanuric chloride as the coupling agent

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Effects of monomethoxypoly(ethylene glycol) modification of ribonuclease on antibody recognition, substrate accessibility and conformational stability

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Immunogenicity of recombinant DNA human insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Resistance and allergy to recombinant human insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Insulin-specific IgG and IgE antibody response in type I diabetic subjects exclusively treated with human insulin (recombinant DNA)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Insulin Allergy: Reaginic Antibodies to Insulin and Proinsulin*

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Physical binding of insulin by gamma globulins of insulin-resistant subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Affinity of IgG-insulin antibodies to human (recombinant DNA) insulin and porcine insulin in insulin-treated diabetic individuals with and without insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Physical stabilization of insulin by glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Synthesis of palmitoyl derivatives of insulin and their biological activities

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

The biological activity and the binding affinity of modified insulins determined on isolated rat fat cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Structure and evolution of insulins: implications for receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Synthesis and characterization of poly(ethylene glycol)-insulin conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Glucose-induced release of glycosylpoly(ethylene glycol) insulin bound to a soluble conjugate of concanavalin A

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Altering the association properties of insulin by amino acid replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Zinc binding, circular dichroism, and equilibrium sedimentation studies on insulin (bovine) and several of its derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Changes in secondary structure follow the dissociation of human insulin hexamers: a circular dichroism study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

The ultraviolet circular dichroism of bovine insulin and desoctapeptide insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

An analysis of the near ultraviolet circular dichroism of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Conformational dynamics of insulin in solution. Circular dichroic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

The relation of conformation and association of insulin to receptor binding; x-ray and circular-dichroism studies on bovine and hystricomorph insulins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Quantitative analysis of protein far UV circular dichroism spectra by neural networks

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

The structure of 2Zn pig insulin crystals at 1.5 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Insulin analogs with improved pharmacokinetic profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Monomeric insulins and their experimental and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Subcutaneous Insulin Absorption Explained by Insulin's Physicochemical Properties: Evidence From Absorption Studies of Soluble Human Insulin and Insulin Analogues in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Molecular structure of insulin: the insulin monomer and its assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

The self-association of zinc-free bovine insulin. Four model patterns and their significance.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Insulin Pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

EQUILIBRIUM ULTRACENTRIFUGATION OF DILUTE SOLUTIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Toward understanding insulin fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Site-specific insulin conjugates with enhanced stability and extended action profile.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Immunogenicity of N-(2-hydroxypropyl)-methacrylamide copolymers--potential hapten or drug carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

The molecular weight ratio of monomethoxypolyethylene glycol (mPEG) to protein determines the immunotolerogenicity of mPEG proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Prevention of collagen-induced arthritis (CIA) by treatment with polyethylene glycol-conjugated type II collagen; distinct tolerogenic property of the conjugated collagen from the native one

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Situation of monomethoxypolyethylene glycol covalently attached to lysozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Depression of T-cell epitope generation by stabilizing hen lysozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Properties of two urate oxidases modified by the covalent attachment of poly(ethylene glycol)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Regulation of delayed-type hypersensitivity to pathogens and alloantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Recombinant soluble form of the human high-affinity receptor for IgE prevents anaphylactic shock in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Suppression of reaginic antibodies with modified allergens. II. Abrogation of reaginic antibodies with allergens conjugated to polyethylene glycol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Insulin degradation: progress and potential

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Therapeutic antibody fragments with prolonged in vivo half-lives

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900025-X

7 January 2021

10.1016/S0169-409X(02)00025-X

Identifiers

DOI

1 reference

3 August 2017

1 reference